×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [us fda]
Home >
us fda
GLP in Bioequivalence Studies
145 views
Quality by Design
787 views
Dave Green – Geograph.org.uk Trade mark erosion: Dangers, pitfalls and adaptation Brett Lewis | Partner Davies Collison Cave.
216 views
The WTO TRIPS Agreement, Innovation and Access to Medicines Does the emperor have any clothes at all? HAI Europe 25th Anniversary Conference, Oct 26 -
214 views
1 st Ibero-American Forum on Metastatic Renal Cell Carcinoma: Establishing A Continuum of Care to Improve Patient Outcomes Daniel Castellano Oncología.
215 views
Statistical Methods for Assessment of Individual/Population Bioequivalence Shein-Chung Chow, Ph.D. Biostatistics and Clinical Data Management Millennium.
219 views
September 16, 2005 Statistical Methods for Testing Carcinogenic Potential of New Drugs in Animal Carcinogenicity Studies Hojin Moon, Ph.D. HMoonnctr.fda.gov.
215 views
2/12/2014 IMS LifeCycle R&D Focus New Product Focus Patent Focus Content, Sources & Updates SLA Pharmaceutical & Health Technology Division Spring Meeting.
214 views
Alex J Mitchell University of Leicester (UK) Acknowledgements Davy Vancampfort, Belgium Marc De Hert, Belgium Weight Gain, Diabetes.
217 views
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies (19-23 September 2005) TRADE, TRIPS AND ACCESS TO MEDICINES Cecilia Oh Department.
214 views
INN Programme, Dr R. Balocco Mattavelli SCT, WIPO – Geneva 18-21 September 2012 International Nonproprietary Names.
219 views
Absenteeism, increased health care costs and decreased productivity due to alcohol and other substance abuse cost Illinois companies about $1,000 per.
220 views
< Previous